Download presentation
Presentation is loading. Please wait.
Published byHortense Harrison Modified over 9 years ago
1
THE MEDICINES CONTROL COUNCIL (MCC) Presentation to the Portfolio Committee on Health 24 June 2008
2
OVERVIEW Mandate of the MCC Legislative responsibilities Description of the MCC and the cluster Medicines Regulatory affairs Process of evaluation of medicines Fees & timelines Strategic plans Budget
3
MCC MANDATE Registration of medicines based on quality efficacy and safety (human & veterinary) Approval of clinical trials Monitoring of safety Response to signals Licensing manufacturers, wholesalers and distributors Provision of information Timely access to medicines
4
LEGISLATIVE RESPONSIBILITIES MINISTER: Appointment of MCC, Appeal Committee against decisions of the MCC and DG, Appointment of registrar and deputy registrar/s, Promulgation of regulations in consultation with MCC, grants exemptions to some sections of the Act in consultation with MCC, determines fees in consultation with Minister of Finance DIRECTOR GENERAL: Release of Information, Issuing of Permits for Psychotropics & Narcotics, Licensing premises, appointment of law enforcement inspectors, appointment of secretariat to MCC, collection of fees
5
LEGISLATIVE RESPONSIBILITIES cont. MEDICINES CONTROL COUNCIL: Approval of Medicines, Licensing of Manufacturers, Distributors & Wholesalers, Registration of Medical Devices, Regulation of Clinical Trials etc REGISTRAR OF MEDICINES : Registration, Secretary executive functions, Delegated authority, licensing, etc INSPECTORS: Law enforcement, Entry, Search and Seizures, Taking samples & conducting tests
6
HISTORY Human medicine regulated for past 41 years Veterinary medicines regulated since 1947 under Act 36 but brought under the ambit of MCC in 1979 Stock remedies still regulated under Act 36 administered by the department of Agriculture
7
HOW THE MCC WORKS BY LAW Obliged to hold at least one meeting every two months Provision for special meetings at the discretion of the chairperson or on request by at least 3 members On request by Minister Decisions are by majority vote except S36 exclusions when a unanimous decision is required Executive committee may exercise all powers of council in between meetings, subject to ratification at first ensuing meeting of council
8
HOW THE MCC WORKS cont. 24 Council members with defined expertise and skills 10 technical Expert committees, varying in numbers from 7 to 22 members 145 members total currently Academic, research and professional backgrounds Drawn from various institutions throughout the country
9
HOW MCC WORKS
10
MEDICINES REGULATORY AFFAIRS CLUSTER (MRA) Secretariat to the MCC All employees of Department of Health Four directorates viz:- Medicines Evaluation & Research (includes Complementary and African Traditional Medicines), Clinical evaluations and Clinical trials (includes pharmacovigilance), Inspectorate(GMP,GCP,GWP,GDP) & law enforcement and Operations & Administration
11
MRA cont. Each directorate supports one or more expert committees Staff complement of 138, comprising 74 technical (health-related) - -3 doctorate -11 masters -2 studying masters -1 studying doctorate -Rest 1st degree qualification
12
MRA cont. Inspectorate – Good manufacturing Practice (GMP), Good Clinical Practice (GCP), Good Laboratory Practice (GLP) – peer reviewed by P&A Committee Licensing manufacturers (currently about 200, wholesalers (about 120 more to be inspected) Another 180 manufacturing sites abroad Law Enforcement – including International Narcotics Board (INCB) issues, Permits in accordance with section 22A of the Act etc Analytical laboratories outsourced
13
PROCESS OF EVALUATION Applications screened by secretariat New chemical entities, clinical trials reviewed by external evaluators Report peer reviewed by relevant expert committee Some internal review for generics (pharmaceutical and analytical, bioequivalence, post –registration minor amendments, standard package inserts - all subject to peer review Committees recommend to MCC for marketing authorisation or rejection
14
FEES APPLICATION New chemical Entity – R30 000 Generic -R12 500 Major Line Ext. – R20 000 Minor variation – R230 Licensing – R3 600
15
FEES CONT. Retention Fees – R550 pa Fast track application –R5 000 Registration – R600 Section 21 Exemptions – R200 Collect about R20 million to R25 million pa Transferred to the Treasury at end of financial year
16
TIMELINES FAST TRACK 9-15 months Generics 18-24 months NCEs 24 –36 months Clinical trial approval 12 – 16 weeks on average No “stop-clock” policy
17
TIMELINES cont. Fast track should be 9 months NCE in mature Regulatory authorities 12 months (TGA Australia, Canada, MHRA Britain, FDA USA) Generics – 3months Clinical Trials – 4 -6 weeks All with stop-clock policy
18
WORKLOAD TRENDS Recvd200220032004200520062007 NCE293162414942+ 12(b) Generic496555647564886912 Total552634718613940966 Fast Tr.4977104125197222 Registe red 427445292769551387
19
CLINICAL TRIALS 2004200520062007 Recvd258269264 Apprvd225240227 Canc.82113 PhaseIV2100 Rejected265 Not apprvd 220
20
STRATEGIC PLANS MCC does not have strategic plans MRA Strategic plans on hard copy Part of DOH plans
21
BUDGET 2007/8 Total allocation R30 554 MCC R2 397 000 MRA R28 157 000
22
BUDGET-MCC & MRA Budget 2008/9 R36.503 million MCC experts remuneration category A committee per Treasury definition –R3.5 million Appointing about 10 to 15 additional Professional staff R18.64 million Administrative staff R3.071 Inspections-R4.5 million Balance admin, stationery, courier, office equipment, airfares, hotel for experts etc.
23
MCC RATES(pa –FTE) MCCR / annumR/dayR/hour Chairperson758 5773011377 Vice-chair644 5802558320 Member564 2552240280 Committees Chairperson673 8422674335 Vice-chair572 6582273285 Member531 8672111264
24
EXPENDITURE 2007/8 ITEMBUDGEXP 000 COM 000 EXP%BAL 000 Comp19579259540132.6-6375 Goods10767136771208138.5-4118 Equip5182623457.14222 Levies0000 House0380-38 Total308641242133.4- 10309
25
EXPENDITURE MCC ITEMBUDG ET EXP 000 COM 000 EXP%BAL 000 Comp157527180172.6-1143 Goods & Serv 822206413252.7-1255 Total2397478213200-2398
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.